195 related articles for article (PubMed ID: 11453713)
1. Power Shortage: clinical trials testing the "homocysteine hypothesis" against a background of folic acid-fortified cereal grain flour.
Bostom AG; Selhub J; Jacques PF; Rosenberg IH
Ann Intern Med; 2001 Jul; 135(2):133-7. PubMed ID: 11453713
[TBL] [Abstract][Full Text] [Related]
2. Total homocysteine lowering treatment among coronary artery disease patients in the era of folic acid-fortified cereal grain flour.
Bostom AG; Jacques PF; Liaugaudas G; Rogers G; Rosenberg IH; Selhub J
Arterioscler Thromb Vasc Biol; 2002 Mar; 22(3):488-91. PubMed ID: 11884295
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of mild fasting hyperhomocysteinemia in renal transplant versus coronary artery disease patients after fortification of cereal grain flour with folic acid.
Bostom AG; Gohh RY; Liaugaudas G; Beaulieu AJ; Han H; Jacques PF; Dworkin L; Rosenberg IH; Selhub J
Atherosclerosis; 1999 Jul; 145(1):221-4. PubMed ID: 10428313
[TBL] [Abstract][Full Text] [Related]
4. Renal insufficiency, vitamin B(12) status, and population attributable risk for mild hyperhomocysteinemia among coronary artery disease patients in the era of folic acid-fortified cereal grain flour.
Liaugaudas G; Jacques PF; Selhub J; Rosenberg IH; Bostom AG
Arterioscler Thromb Vasc Biol; 2001 May; 21(5):849-51. PubMed ID: 11348885
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of vitamin therapy to lower plasma homocysteine levels for the prevention of coronary heart disease: effect of grain fortification and beyond.
Tice JA; Ross E; Coxson PG; Rosenberg I; Weinstein MC; Hunink MG; Goldman PA; Williams L; Goldman L
JAMA; 2001 Aug 22-29; 286(8):936-43. PubMed ID: 11509058
[TBL] [Abstract][Full Text] [Related]
6. [Public health control of hyperhomocysteinemia and its consequences].
Czeizel E; Kalina A
Orv Hetil; 2003 Oct; 144(40):1981-9. PubMed ID: 14626640
[TBL] [Abstract][Full Text] [Related]
7. Clinical trials testing the homocysteine hypothesis.
Carlsson CM; Stein JH
Ann Intern Med; 2002 Aug; 137(4):295-6. PubMed ID: 12186526
[No Abstract] [Full Text] [Related]
8. Lack of association between plasma homocysteine and angiographic coronary artery disease in the era of fortification of cereal grain flour with folic acid.
Brilakis ES; McConnell JP; Ballman KV; Klee GG; Berger PB
Atherosclerosis; 2002 Dec; 165(2):375-81. PubMed ID: 12417290
[TBL] [Abstract][Full Text] [Related]
9. Relationship between plasma homocysteine and vitamin status in the Framingham study population. Impact of folic acid fortification.
Selhub J; Jacques PF; Bostom AG; Wilson PW; Rosenberg IH
Public Health Rev; 2000; 28(1-4):117-45. PubMed ID: 11411265
[TBL] [Abstract][Full Text] [Related]
10. The Chilean flour folic acid fortification program reduces serum homocysteine levels and masks vitamin B-12 deficiency in elderly people.
Hirsch S; de la Maza P; Barrera G; Gattás V; Petermann M; Bunout D
J Nutr; 2002 Feb; 132(2):289-91. PubMed ID: 11823592
[TBL] [Abstract][Full Text] [Related]
11. Folate, vitamin B12 and homocysteine status in women of childbearing age: baseline data of folic acid wheat flour fortification in Iran.
Abdollahi Z; Elmadfa I; Djazayeri A; Sadeghian S; Freisling H; Mazandarani FS; Mohamed K
Ann Nutr Metab; 2008; 53(2):143-50. PubMed ID: 18997463
[TBL] [Abstract][Full Text] [Related]
12. Vitamin supplements and cardiovascular risk: review of the randomized trials of homocysteine-lowering vitamin supplements.
Clarke R; Armitage J
Semin Thromb Hemost; 2000; 26(3):341-8. PubMed ID: 11011852
[TBL] [Abstract][Full Text] [Related]
13. Breakfast cereal fortified with folic acid, vitamin B-6, and vitamin B-12 increases vitamin concentrations and reduces homocysteine concentrations: a randomized trial.
Tucker KL; Olson B; Bakun P; Dallal GE; Selhub J; Rosenberg IH
Am J Clin Nutr; 2004 May; 79(5):805-11. PubMed ID: 15113718
[TBL] [Abstract][Full Text] [Related]
14. Fortification of flour with folic acid.
Berry RJ; Bailey L; Mulinare J; Bower C;
Food Nutr Bull; 2010 Mar; 31(1 Suppl):S22-35. PubMed ID: 20629350
[TBL] [Abstract][Full Text] [Related]
15. Treatment of hyperhomocysteinemia in hemodialysis patients and renal transplant recipients.
Bostom AG; Shemin D; Gohh RY; Beaulieu AJ; Bagley P; Massy ZA; Jacques PF; Dworkin L; Selhub J
Kidney Int Suppl; 2001 Feb; 78():S246-52. PubMed ID: 11169020
[TBL] [Abstract][Full Text] [Related]
16. Dietary strategies for lowering homocysteine concentrations.
Riddell LJ; Chisholm A; Williams S; Mann JI
Am J Clin Nutr; 2000 Jun; 71(6):1448-54. PubMed ID: 10837284
[TBL] [Abstract][Full Text] [Related]
17. Reduction of plasma homocyst(e)ine levels by breakfast cereal fortified with folic acid in patients with coronary heart disease.
Malinow MR; Duell PB; Hess DL; Anderson PH; Kruger WD; Phillipson BE; Gluckman RA; Block PC; Upson BM
N Engl J Med; 1998 Apr; 338(15):1009-15. PubMed ID: 9535664
[TBL] [Abstract][Full Text] [Related]
18. Homocysteine-lowering trials for prevention of heart disease and stroke.
Clarke R
Semin Vasc Med; 2005 May; 5(2):215-22. PubMed ID: 16047274
[TBL] [Abstract][Full Text] [Related]
19. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial.
Toole JF; Malinow MR; Chambless LE; Spence JD; Pettigrew LC; Howard VJ; Sides EG; Wang CH; Stampfer M
JAMA; 2004 Feb; 291(5):565-75. PubMed ID: 14762035
[TBL] [Abstract][Full Text] [Related]
20. Homocysteine-lowering and cardiovascular disease outcomes in kidney transplant recipients: primary results from the Folic Acid for Vascular Outcome Reduction in Transplantation trial.
Bostom AG; Carpenter MA; Kusek JW; Levey AS; Hunsicker L; Pfeffer MA; Selhub J; Jacques PF; Cole E; Gravens-Mueller L; House AA; Kew C; McKenney JL; Pacheco-Silva A; Pesavento T; Pirsch J; Smith S; Solomon S; Weir M
Circulation; 2011 Apr; 123(16):1763-70. PubMed ID: 21482964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
